e-therapeutics plc (LON:ETX – Get Free Report)’s stock price crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 11.94 ($0.15) and traded as low as GBX 9.88 ($0.12). e-therapeutics shares last traded at GBX 10.20 ($0.13), with a volume of 4,338,035 shares trading hands.
e-therapeutics Stock Up 3.8 %
The stock has a 50 day simple moving average of GBX 12.94 and a 200-day simple moving average of GBX 11.94. The firm has a market cap of £59.60 million, a PE ratio of -510.00 and a beta of 0.48. The company has a debt-to-equity ratio of 0.33, a current ratio of 22.20 and a quick ratio of 20.13.
About e-therapeutics
e-therapeutics plc engages in drug discovery research activities in the United Kingdom. It offers HepNet, a proprietary, hepatocyte-specific, and computational biology platform that addresses key limitations of the biopharmaceutical industry, including extracting value from big data, addressing complex diseases, and improving translatability in research and development; and GalOmic, a RNA interference (RNAi) chemistry platform, which enables the generation of GalNAc-conjugated short interfering RNA drug candidates for hepatocyte-specific gene silencing through RNAi of any target gene identified by HepNet.
Further Reading
- Five stocks we like better than e-therapeutics
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- United Airlines Soars on Earnings Beat
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Roth IRA Calculator: Calculate Your Potential Returns
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for e-therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for e-therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
